Invite People

Share 4Engineers with your friends and help them get started!

Emails
Enter multiple email addresses by separating it with a comma.
Back
4Engineers

Evonik investing $100 million to expand API production site in Indiana

This article was originally posted on Chemical Engineering Online.
Summary
Evonik Industries is investing $100 million to expand and strengthen manufacturing at its Tippecanoe Labs in Lafayette, Indiana, one of the world’s largest active pharmaceutical ingredient (API) production facilities.

What impact do you think this expansion will have on U.S. API supply chains and pharmaceutical manufacturing competitiveness in the Midwest?

Evonik Industries AG (Essen, Germany) is making a significant investment to strengthen manufacturing capabilities at its Tippecanoe Labs site in Lafayette, Indiana. The site is home to one of the world’s largest facilities for the production of active pharmaceutical ingredients (APIs)

The post Evonik investing $100 million to expand API production site in Indiana appeared first on Chemical Engineering.

Login to comment

Login
Report content
Reason Description